Drugs / INTERCOAT
last change Mar 2016 re-read 3 minutes ago

INTERCOAT

Developed for
Asherman syndrome · benign neoplasm of corpus uteri · endometrial polyp
Investigated by
Carmel Medical Center

Trials 1

201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT01637974 Dec 2012 → Mar 2016 Asherman syndrome, benign neoplasm of corpus uteri, endometrial polyp Carmel Medical Center Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as INTERCOAT ClinicalTrials.gov intervention name — accepted as the source's own label NCT01637974 ↗
Route Other “Applying INTERCOAT in the intrauterine cavity at the end of the hysteroscopic surgery” NCT01637974 ↗